{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:52:58Z","timestamp":1771951978882,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/bcr1830","type":"journal-article","created":{"date-parts":[[2009,8,17]],"date-time":"2009-08-17T05:46:20Z","timestamp":1250487980000},"source":"Crossref","is-referenced-by-count":16,"title":["Adjuvant endocrine therapy for premenopausal women with early breast cancer"],"prefix":"10.1186","volume":"9","author":[{"given":"Ting","family":"Bao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,12,17]]},"reference":[{"key":"1794_CR1","first-page":"104","volume-title":"Lancet","author":"GT Beatson","year":"1896","unstructured":"Beatson GT: On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases. Lancet. 1896, 104-107. 10.1016\/S0140-6736(01)72307-0. 162\u2013165"},{"key":"1794_CR2","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1136\/bmj.317.7167.1246","volume":"317","author":"MJ Clarke","year":"1998","unstructured":"Clarke MJ: Ovarian ablation in breast cancer, 1896 to 1998: milestones along hierarchy of evidence from case report to Cochrane review. BMJ. 1998, 317: 1246-1248.","journal-title":"BMJ"},{"key":"1794_CR3","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists' Collaborative Group","year":"2005","unstructured":"Early Breast Cancer Trialists' Collaborative Group: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005, 365: 1687-1717. 10.1016\/S0140-6736(05)66544-0.","journal-title":"Lancet"},{"key":"1794_CR4","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/annonc\/mdm271","volume":"18","author":"A Goldhirsch","year":"2007","unstructured":"Goldhirsch A, Wood W, Gelber R, Coates AS, Th\u00fcrlimann B, Senn H-J, Panel Members: Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer. Ann Oncol. 2007, 18: 1133-1144. 10.1093\/annonc\/mdm271.","journal-title":"Ann Oncol"},{"key":"1794_CR5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0959-8049(02)00810-9","volume":"39","author":"JF Robertson","year":"2003","unstructured":"Robertson JF, Blamey RW: The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women. Eur J Cancer. 2003, 39: 861-869. 10.1016\/S0959-8049(02)00810-9.","journal-title":"Eur J Cancer"},{"key":"1794_CR6","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1200\/JCO.2005.11.050","volume":"23","author":"S Dellapasqua","year":"2005","unstructured":"Dellapasqua S, Colleoni M, Gelber RD, Goldhirsch A: Adjuvant endocrine therapy for premenopausal women with early breast cancer. J Clin Oncol. 2005, 23: 1736-1750. 10.1200\/JCO.2005.11.050.","journal-title":"J Clin Oncol"},{"key":"1794_CR7","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0140-6736(07)60778-8","volume":"369","author":"J Cuzick","year":"2007","unstructured":"Cuzick J, Ambroisine L, Davidson N, Jakesz R, Kaufmann M, Regan M, Sainsbury R: Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials. Lancet. 2007, 369: 1711-1723. 10.1016\/S0140-6736(07)60778-8.","journal-title":"Lancet"},{"key":"1794_CR8","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1056\/NEJMoa012158","volume":"346","author":"TR Rebbeck","year":"2002","unstructured":"Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, et al: Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med. 2002, 346: 1616-1622. 10.1056\/NEJMoa012158.","journal-title":"N Engl J Med"},{"key":"1794_CR9","doi-asserted-by":"publisher","first-page":"9312","DOI":"10.1200\/JCO.2005.03.3266","volume":"23","author":"MP Goetz","year":"2005","unstructured":"Goetz MP, Rae JM, Suman VJ, Safgren SL, Ames MM, Visscher DW, Reynolds C, Couch FJ, Lingle WL, Flockhart DA, et al: Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. J Clin Oncol. 2005, 23: 9312-9318. 10.1200\/JCO.2005.03.3266.","journal-title":"J Clin Oncol"},{"key":"1794_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2217\/14622416.8.1.1","volume":"8","author":"J Stebbing","year":"2007","unstructured":"Stebbing J, Stearns V, Davidson NE: Role of CYP2D6 testing in selection of endocrine therapy for breast cancer. Pharmacogenomics. 2007, 8: 1-3. 10.2217\/14622416.8.1.1.","journal-title":"Pharmacogenomics"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/bcr1830\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr1830.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr1830.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T23:40:30Z","timestamp":1498261230000},"score":1,"resource":{"primary":{"URL":"http:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr1830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["1794"],"URL":"https:\/\/doi.org\/10.1186\/bcr1830","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]},"article-number":"115"}}